ArticleNPJ breast cancer2019

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel.

Sorbarikor Piawah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.